Stay updated on Tirzepatide in HFpEF & Obesity Clinical Trial

Sign up to get notified when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tirzepatide in HFpEF & Obesity Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T08:25:42.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now announces Revision: v3.1.0 and removes four drug-safety related topics, indicating content reorganization and scope narrowing.
    Difference
    0.2%
    Check dated 2025-09-28T03:01:01.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added the new Revision: v3.0.2, replacing v3.0.1. The Back to Top element has been removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:42:51.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated to version 3.0.1, which includes a new study on the effects of Tirzepatide in patients with heart failure and type 2 diabetes, while the previous version 3.0.0 has been removed.
    Difference
    2%
    Check dated 2025-09-06T15:24:26.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has added significant new content related to the SUMMIT trial, including multiple publications and detailed location information for various regions, while also removing some previously listed locations and terms related to heart failure and cardiovascular diseases.
    Difference
    23%
    Check dated 2025-08-30T12:04:28.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated to include new results and metrics related to heart failure outcomes, including specific measurements and assessments of participant health status, while some previous metrics and reporting dates have been removed.
    Difference
    27%
    Check dated 2025-08-23T08:03:03.000Z thumbnail image

Stay in the know with updates to Tirzepatide in HFpEF & Obesity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.